|
|
|
|
Bayer Files Lawsuit Against Teva
Lawsuit concerns Teva's application for approval to market Levitra for the treatment of erectile dysfunction Bayer Schering and Bayer HealthCare together with Schering have filed a patent infringement lawsuit in the US Federal Court in the...
|
|
|
Sanofi-aventis Receives FDA Approval For Multaq
Multaq to treat patients with atrial fibrillation or atrial flutter Sanofi-aventis has received FDA approval for Multaq (dronedarone) 400mg tablets for patients with atrial fibrillation (AF) or atrial flutter (AFL).The FDA approval is...
|
|
|
Dow To Streamline Manufacturing Footprint
Calls for shutdown of a number of manufacturing assets, including ethylene and ethylene-derivative assets The board of directors of Dow has approved a restructuring plan which calls for the shutdown of a number of manufacturing assets,...
|
|
|
J&J, Elan Sign Agreement For Alzheimers Immunotherapy Program
Collaboration to research, develop and commercialize selective products for treatment and prevention of neurodegenerative conditions Related News Letter raises issues regarding the potential abuse deterrent benefits of Acurox ...Business...
|
|
|
Alcon Discontinues Trials For Anecortave Acetate
Amount of IOP reduction and responder rate provided by the highest dose, were not sufficient to support the approach Related News Patient to be randomised to receive once-daily dose of placebo, tiotropium bromide or 50g of NVA237 ...
|
|
|
Eisai Provides Update On Aricept
Plans to complete ongoing studies to provide important information on the therapeutic approach for Alzheimers disease Related News To develop therapeutic monoclonal antibodies for treatment of various forms of cancer and infectious ...
|
|
|
Lundbeck Presents Positive Results For Depressive Disorder Phase II Study
Study compared efficacy of three doses of Lu AA24530, 5mg, 10mg and 20 mg, to that of placebo Related News Business comprises a portfolio of 13 branded pharmaceuticals ...GSKs Irish combination patent for Seretide termed invalid ...
|
|
|
Acura, King Receive FDA' Complete Response Letter For Acurox
Letter raises issues regarding the potential abuse deterrent benefits of Acurox Related News Collaboration to research, develop and commercialize selective products for treatment and prevention ...Wyeth to support the discovery, research...
|
|
|
Myriad Genetics Spins Off Research, Pharmaceutical Business
Myriad Genetics to claim approximately $400 million in tax deductions Myriad Genetics has completed the spin off of Myriad Pharmaceuticals.Also, the company has received a Private Letter Ruling from the Internal Revenue Service. It...
|
|
|
GSK Extends Product Portfolio In Middle East, North Africa
Business comprises a portfolio of 13 branded pharmaceuticals Related News Collaboration to research, develop and commercialize selective products for treatment and prevention ...Study compared efficacy of three doses of Lu AA24530, 5mg,...
|
